B-type natriuretic peptide (BNP) was first isolated in porcine brain tissues in 1988 and therefore
named initially “brain” natriuretic peptide. … , thus identifying ventricular cardiomyocytes as …

… of natriuretic peptide levels in hospitalized obese patients with … pro‐B‐type natriuretic peptide)
levels by obesity category and … in patients with HF p EF hospitalized for acute heart failure. …

… Natriuretic peptides (NPs, B-type natriuretic peptide /BNP and NT-proBNP) are … of heart
failure (HF). It has been demonstrated that an inverse relationship exists between obesity, …

… and monitoring treatment efficacy in patients with heart failure (HF). Both … concentrations
of natriuretic peptides. Generally, testosterone suppresses natriuretic peptide concentrations …

… suppressing BNP levels (46, 47). It is therefore likely that β 1 -AR blockade was associated
with increased BNP levels … The study patients were Japanese among whom obesity is not …

… high B-type natriuretic peptide (BNP) levels would be expected: 1) hospitalization for heart
failure (HF); 2) abnormal cardiac … BNP levels were lower in obese compared with nonobese …

… , obese individuals both with and without heart failure, consistently exhibit substantially lower
plasma NP concentrations, including B-type natriuretic peptide (… similar suppression of both …

… ) levels and heart failure status, including B-type natriuretic peptide (BNP) levels, in 625 patients
with cardiovascular … T3 and T4 also exert a negative feedback effect that suppresses the …

… (BNP) in individuals with obesity. We aimed to estimate the … , and suppression of vascular
smooth muscle and cardiac muscle … heart disease (arrhythmia, heart failure, and ischemic heart …

… of the physiological effects of natriuretic peptides (NPs), including the B-type (BNP), may be
… protective mechanism against I/R injury with suppression of both infarct size and myocardial …